CUSIP: 00289Y107
What is CUSIP 00289Y107?
CUSIP 00289Y107 identifies ABEO - ABEONA THERAPEUTICS INC - COM in SEC 13F datasets.
Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.
Open recent reporting periods for CUSIP 00289Y107:
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q1 | 0 | $0 | -$13,066 | 0 | |
| 2024 Q4 | 2,350 | $13,066 | +$13,066 | $5.56 | 1 |
| 2022 Q4 | 0 | $0 | -$281,000 | 0 | |
| 2022 Q3 | 153,702 | $281,000 | -$10,316,109 | $1.61 | 2 |
| 2022 Q2 | 20,873,758 | $4,338,025 | -$3,565,661 | $0.21 | 35 |
| 2022 Q1 | 32,609,380 | $10,277,038 | -$2,038,846 | $0.31 | 46 |
| 2021 Q4 | 40,902,465 | $13,669,979 | +$3,297,234 | $0.34 | 45 |
| 2021 Q3 | 25,219,481 | $28,251,178 | -$3,241,034 | $1.12 | 51 |
| 2021 Q2 | 27,815,873 | $43,416,187 | -$5,850,446 | $1.56 | 65 |
| 2021 Q1 | 31,075,128 | $58,418,929 | -$1,878,954 | $1.88 | 69 |
| 2020 Q4 | 32,419,497 | $50,901,641 | -$1,664,634 | $1.57 | 69 |
| 2020 Q3 | 35,924,992 | $36,686,570 | -$14,321,084 | $1.02 | 73 |
| 2020 Q2 | 43,438,319 | $126,435,760 | -$1,417,436 | $2.92 | 77 |
| 2020 Q1 | 44,494,860 | $93,349,190 | -$36,312,820 | $2.10 | 78 |
| 2019 Q4 | 55,008,923 | $179,886,101 | +$80,967,799 | $3.27 | 85 |
| 2019 Q3 | 28,565,456 | $64,562,551 | -$3,332,761 | $2.26 | 77 |
| 2019 Q2 | 28,969,765 | $138,472,723 | -$19,625,407 | $4.78 | 93 |
| 2019 Q1 | 31,271,523 | $230,147,728 | -$9,348,459 | $7.36 | 83 |
| 2018 Q4 | 32,565,185 | $232,447,763 | -$24,647,383 | $7.14 | 97 |
| 2018 Q3 | 34,766,258 | $444,445,898 | -$24,732,558 | $12.80 | 104 |
| 2018 Q2 | 36,551,563 | $584,822,416 | +$61,355,864 | $16.00 | 92 |
| 2018 Q1 | 32,800,697 | $470,553,406 | +$46,998,758 | $14.35 | 88 |
| 2017 Q4 | 29,294,827 | $464,314,681 | +$152,009,642 | $15.85 | 93 |
| 2017 Q3 | 19,617,144 | $334,470,272 | +$83,896,681 | $17.05 | 73 |
| 2017 Q2 | 15,387,716 | $98,477,237 | +$8,202,570 | $6.40 | 64 |
| 2017 Q1 | 14,322,381 | $71,554,911 | -$1,244,232 | $5.00 | 55 |
| 2016 Q4 | 14,847,454 | $72,016,000 | +$36,565,243 | $4.85 | 53 |
| 2016 Q3 | 6,957,554 | $41,622,904 | +$3,994,605 | $6.00 | 37 |
| 2016 Q2 | 6,687,973 | $26,727,000 | +$8,677,265 | $2.36 | 31 |
| 2016 Q1 | 7,604,471 | $19,462,748 | -$398,251 | $2.56 | 42 |
| 2015 Q4 | 7,729,605 | $25,971,508 | +$772,388 | $3.36 | 42 |
| 2015 Q3 | 7,436,105 | $30,116,417 | +$12,922,093 | $4.05 | 40 |
| 2015 Q2 | 4,216,119 | $21,329,638 | +$21,329,638 | $5.06 | 40 |